Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
TQ-B3525
i
Other names:
TQ-B3525
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Sino Biopharm
Drug class:
PIK3CA inhibitor, PI3Kδ inhibitor
Related drugs:
‹
alpelisib (80)
copanlisib (32)
GDC-0032 (22)
CYH33 (8)
inavolisib (4)
LX-086 (3)
AZD8835 (1)
HS-10352 (1)
BPI-21668 (0)
SL-901 (0)
TOS-358 (0)
MLN1117 (0)
idelalisib (29)
duvelisib (26)
umbralisib (8)
INCB50465 (6)
RP6530 (6)
BR101801 (1)
CB-006-3 (1)
linperlisib (1)
ACP-319 (0)
BGB-10188 (0)
CVL237 (0)
HSB-510 (0)
ZX-101A (0)
GS-9820 (0)
HMPL-689 (0)
SHC014748M (0)
INCB040093 (0)
IOA-244 (0)
ME-401 (0)
alpelisib (80)
copanlisib (32)
GDC-0032 (22)
CYH33 (8)
inavolisib (4)
LX-086 (3)
AZD8835 (1)
HS-10352 (1)
BPI-21668 (0)
SL-901 (0)
TOS-358 (0)
MLN1117 (0)
idelalisib (29)
duvelisib (26)
umbralisib (8)
INCB50465 (6)
RP6530 (6)
BR101801 (1)
CB-006-3 (1)
linperlisib (1)
ACP-319 (0)
BGB-10188 (0)
CVL237 (0)
HSB-510 (0)
ZX-101A (0)
GS-9820 (0)
HMPL-689 (0)
SHC014748M (0)
INCB040093 (0)
IOA-244 (0)
ME-401 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login